Article, 2022

Rapid in vitro and in vivo Evaluation of Antimicrobial Formulations Using Bioluminescent Pathogenic Bacteria.

In: Bio-protocol, ISSN 2331-8325, Volume 12, 2, Page e4302, 10.21769/bioprotoc.4302

Contributors (2)

Schmidtchen, Artur (0000-0001-9209-3141) [1] [2] [3] Puthia, Manoj (0000-0001-6048-7234) [3]


  1. [1] Copenhagen Wound Healing Center, Bispebjerg Hospital, Department of Biomedical Sciences, University of Copenhagen, DK-2400, Denmark.
  2. [2] Skåne University Hospital
  3. [NORA names: Sweden; Europe, EU; Nordic; OECD]
  4. [3] Lund University
  5. [NORA names: Sweden; Europe, EU; Nordic; OECD]


Basic and translational research needs rapid methods to test antimicrobial formulations. Bioluminescent bacteria and advanced imaging systems capable of acquiring bioluminescence enable us to quickly and longitudinally evaluate the efficacy of antimicrobials. Conventional approaches, such as radial diffusion and viable count assays, are time-consuming and do not allow for longitudinal analysis. Bioluminescence imaging is sensitive and gives vital spatial and temporal information on the infection status in the body. Here, using bioluminescent Pseudomonas aeruginosa, we describe an in vitro and an in vivo approach to rapidly evaluate the antimicrobial efficacy of the host-defense peptide TCP-25. Graphic abstract: Evaluation of antimicrobials using bioluminescent bacteria.